Zobrazeno 1 - 7
of 7
pro vyhledávání: '"R F, Marschke"'
Autor:
J A, Bonner, W L, McGinnis, P J, Stella, R F, Marschke, J A, Sloan, E G, Shaw, J A, Mailliard, E T, Creagan, R K, Ahuja, P A, Johnson
Publikováno v:
Cancer. 82(6)
A three-arm Phase III randomized trial was performed to compare response rates, time to local or distant progression, and survival for patients with unresectable (Stage IIIA or IIIB) nonsmall cell lung carcinoma treated with standard fractionated tho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b9bf3a0d075ef238b2c1f72bc9afe056
https://pubmed.ncbi.nlm.nih.gov/9506347
https://pubmed.ncbi.nlm.nih.gov/9506347
Autor:
J T, Schleusener, H D, Tazelaar, S H, Jung, S S, Cha, P J, Cera, J L, Myers, E T, Creagan, R M, Goldberg, R F, Marschke
Publikováno v:
Cancer. 77(7)
Neuroendocrine differentiation can be identified in 10-30% of patients with nonsmall cell lung carcinoma (NSCLC) by immunohistochemical or electron microscopic techniques. However, its clinical significance is not well established.Tumors from 107 pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::94d60ddab7cfd27d72aaaa4eabfef38f
https://pubmed.ncbi.nlm.nih.gov/8608504
https://pubmed.ncbi.nlm.nih.gov/8608504
Autor:
M H, Veeder, J R, Jett, J Q, Su, J A, Mailliard, J F, Foley, R J, Dalton, P S, Etzell, R F, Marschke, C G, Kardinal, A W, Maksymiuk
Publikováno v:
Cancer. 70(9)
In an effort to confirm the efficacy of mitomycin C against metastatic squamous cell lung carcinoma and to compare the efficacy of single-agent therapy with a combination containing cisplatin, the authors conducted a randomized Phase III trial of mit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e82797efb26dd60948aae095dbb36821
https://pubmed.ncbi.nlm.nih.gov/1394057
https://pubmed.ncbi.nlm.nih.gov/1394057
Autor:
Anthony J. Jaslowski, Nathan R. Foster, John W. Kugler, Fernando Quevedo, R. F. Marschke, Steven R. Alberts, Robert R. McWilliams, E. L. Friedman, J. R. Sande
Publikováno v:
Journal of Clinical Oncology. 25:4578-4578
4578 Background: Gemcitabine is commonly used in patients with cholangiocarcinoma with a response rate of 20–30% and median overall survival of 6–10 months. Pemetrexed’s mechanism of action and tolerability in patients with hepatic dysfunction
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::06d292f007d50693369f41bb8686a5a3
https://doi.org/10.1200/jco.2007.25.18_suppl.4578
https://doi.org/10.1200/jco.2007.25.18_suppl.4578
Autor:
Weitz, J. J., Jr., R. F. Marschke, Sloan, J. A., Grill, J. P., Jett, J. R., Knost, J. A., Hatfield, A. K., Zenk, D. W., Bate, W. W., Schaefer, P. L.
Publikováno v:
Lung Cancer; 2000, Vol. 28 Issue: 2 p157-162, 6p
Publikováno v:
Mayo Clinic proceedings. 56(7)
The Mayo Clinic experience with superior vena cava obstruction during the last 20 years was reviewed. The diagnosis of superior vena cava obstruction is often made at the bedside. Typical symptoms include suffusion, dyspnea, cough, and, less commonly
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::fbfb720dc4a74e8d57f1d5c1511a1e82
https://pubmed.ncbi.nlm.nih.gov/7253702
https://pubmed.ncbi.nlm.nih.gov/7253702
Autor:
J E, Krook, J N, Ingle, S J, Green, W D, Bowman, L K, Everson, H E, Windschitl, R F, Marschke, J A, Laurie, S A, Cullinan, D M, Pfeifle
Publikováno v:
Cancer treatment reports. 69(4)
The purpose of this study was to determine if tamoxifen added to the efficacy of a CFP (cyclophosphamide, 5-FU, and prednisone) regimen. One hundred thirty-one postmenopausal women with advanced breast cancer without prior chemotherapy exposure were
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::769a02a19b57a4b2844e455591e65176
https://pubmed.ncbi.nlm.nih.gov/3888386
https://pubmed.ncbi.nlm.nih.gov/3888386